Table 2. Refugee Characteristics Predictive of Vaccine Receipt (N = 2,269), Massachusetts Department of Public Health, 2011–2013.
| Characteristic | Human Papillomavirus | Hepatitis B Virus |
|---|---|---|
| Age, y (reference: 9–12 y), adjusted odds ratio (95% confidence interval) | ||
| 13–26 years | 0.74 (0.60–0.93) | 0.49 (0.37–0.63) |
| Sex (reference: female), adjusted odds ratio (95% confidence interval) | ||
| Male | 0.62 (0.52–0.74) | 1.1 (0.94–1.3) |
| Arrival year (reference: 2011), adjusted odds ratio (95% confidence interval) | ||
| 2012–2013 | 1.6 (1.3–1.9) | 0.87 (0.70–1.1) |
| Hepatitis B virus surface antigen (reference: negative), adjusted odds ratio (95% confidence interval) | ||
| Positive | Does not apply | 0.13 (0.07–0.24) |
| Hepatitis B virus surface antibody (reference: negative), adjusted odds ratio (95% confidence interval) | ||
| Positive | Does not apply | 0.42 (0.34–0.52) |
| Region, % (n) [P valuea] | ||
| Sub-Saharan Africa, excluding Somalia (N = 481) | 63 (302) [Reference] | 68 (326) [Reference] |
| Somalia (N = 255) | 51 (129) [.001] | 50 (127) [<.001] |
| Near East, excluding Iraq (N = 24) | 29 (7) [.002] | 42 (10) [.01] |
| Iraq (N = 571) | 61 (350) [.62] | 59 (338) [.004] |
| South and Central Asia, excluding Bhutan (N = 29) | 41 (12) [.03] | 57 (17) [.31] |
| Bhutan (N = 538) | 56 (301) [.03] | 68 (364) [.97] |
| East Asia and Pacific (N = 214) | 56 (119) [.07] | 66 (141) [.49] |
| Europe and Eurasia (N = 64) | 23 (15) [<.001] | 50 (32) [.006] |
| Western Hemisphere (N = 93) | 48 (45) [.009] | 71 (66) [.61] |
a
χ2 analysis.